These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1951574)

  • 1. Mode of action of anti-Candida drugs: focus on terconazole and other ergosterol biosynthesis inhibitors.
    Vanden Bossche H; Marichal P
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 2):1193-9. PubMed ID: 1951574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical basis for the activity and selectivity of oral antifungal drugs.
    Vanden Bossche H; Marichal P; Gorrens J; Coene MC
    Br J Clin Pract Suppl; 1990 Sep; 71():41-6. PubMed ID: 2091733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Candida drugs--the biochemical basis for their activity.
    Vanden Bossche H; Willemsens G; Marichal P
    Crit Rev Microbiol; 1987; 15(1):57-72. PubMed ID: 3319421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terbinafine: mode of action and properties of the squalene epoxidase inhibition.
    Ryder NS
    Br J Dermatol; 1992 Feb; 126 Suppl 39():2-7. PubMed ID: 1543672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel sequence element is involved in the transcriptional regulation of expression of the ERG1 (squalene epoxidase) gene in Saccharomyces cerevisiae.
    Leber R; Zenz R; Schröttner K; Fuchsbichler S; Pühringer B; Turnowsky F
    Eur J Biochem; 2001 Feb; 268(4):914-24. PubMed ID: 11179957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A non-azole inhibitor of lanosterol 14 alpha-methyl demethylase in Candida albicans.
    Capobianco JO; Doran CC; Goldman RC; De B
    J Antimicrob Chemother; 1992 Dec; 30(6):781-90. PubMed ID: 1289352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ergosterol biosynthesis inhibition by the thiocarbamate antifungal agents tolnaftate and tolciclate.
    Ryder NS; Frank I; Dupont MC
    Antimicrob Agents Chemother; 1986 May; 29(5):858-60. PubMed ID: 3524433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antifungal agents on ergosterol biosynthesis in Candida albicans and Trichophyton mentagrophytes: differential inhibitory sites of naphthiomate and miconazole.
    Morita T; Nozawa Y
    J Invest Dermatol; 1985 Nov; 85(5):434-7. PubMed ID: 3902987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific inhibition of fungal sterol biosynthesis by SF 86-327, a new allylamine antimycotic agent.
    Ryder NS
    Antimicrob Agents Chemother; 1985 Feb; 27(2):252-6. PubMed ID: 4039119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of 14 alpha-desmethyl sterol synthesis in Candida albicans by terconazole, a new triazole antimycotic.
    Isaacson DM; Tolman EL; Tobia AJ; Rosenthale ME; McGuire JL; Vanden Bossche H; Janssen PA
    J Antimicrob Chemother; 1988 Mar; 21(3):333-43. PubMed ID: 3129389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of squalene epoxidase inhibitors on Candida albicans.
    Georgopapadakou NH; Bertasso A
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1779-81. PubMed ID: 1416865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of terconazole and other azole antifungal agents on the sterol and carbohydrate composition of Candida albicans.
    Pfaller MA; Riley J; Koerner T
    Diagn Microbiol Infect Dis; 1990; 13(1):31-5. PubMed ID: 2184984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of azole antifungal antibiotics with cytochrome P-450-dependent 14 alpha-sterol demethylase purified from Candida albicans.
    Hitchcock CA; Dickinson K; Brown SB; Evans EG; Adams DJ
    Biochem J; 1990 Mar; 266(2):475-80. PubMed ID: 2180400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic eburicol accumulation drives the antifungal activity of azoles against Aspergillus fumigatus.
    Elsaman H; Golubtsov E; Brazil S; Ng N; Klugherz I; Martin R; Dichtl K; Müller C; Wagener J
    Nat Commun; 2024 Jul; 15(1):6312. PubMed ID: 39060235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical approaches to selective antifungal activity. Focus on azole antifungals.
    Vanden Bossche H; Marichal P; Gorrens J; Coene MC; Willemsens G; Bellens D; Roels I; Moereels H; Janssen PA
    Mycoses; 1989; 32 Suppl 1():35-52. PubMed ID: 2561184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of sterol 14 alpha-demethylation of Candida albicans with NND-502, a novel optically active imidazole antimycotic agent.
    Niwano Y; Koga H; Kodama H; Kanai K; Miyazaki T; Yamaguchi H
    Med Mycol; 1999 Oct; 37(5):351-5. PubMed ID: 10520160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of an azole-resistant Candida glabrata isolate.
    vanden Bossche H; Marichal P; Odds FC; Le Jeune L; Coene MC
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2602-10. PubMed ID: 1482129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of azole antifungal agents with cytochrome P-45014DM purified from Saccharomyces cerevisiae microsomes.
    Yoshida Y; Aoyama Y
    Biochem Pharmacol; 1987 Jan; 36(2):229-35. PubMed ID: 3545213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition and interaction of cytochrome P450 of Candida krusei with azole antifungal drugs.
    Venkateswarlu K; Denning DW; Kelly SL
    J Med Vet Mycol; 1997; 35(1):19-25. PubMed ID: 9061581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cross-resistance of Candida albicans to several different families of antifungals with ergosterol biosynthesis-inhibiting activity].
    Hiratani T; Yamaguchi H
    Jpn J Antibiot; 1994 Feb; 47(2):125-8. PubMed ID: 8151906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.